People in the News: Lou Tartaglia, John Borgeson | GenomeWeb

Solstice Biologics has named Lou Tartaglia as its president and CEO, as well as a member of its board of directors.

Tartaglia was previously a partner at Third Rock Ventures, and before that was a senior vice president at GeneLogic.

Solstice also said that it has appointed John Borgeson as its CFO. He acted as a financial advisor to Solstice from its inception earlier this year, and previously held a variety of roles at Pfizer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.